Found: 43
Select item for more details and to access through your institution.
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2257, doi. 10.3390/jcm13082257
- By:
- Publication type:
- Article
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
- Published in:
- PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0292435
- By:
- Publication type:
- Article
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 12, p. 6416, doi. 10.1007/s00415-022-11276-8
- By:
- Publication type:
- Article
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
- Published in:
- Cardiology & Therapy, 2022, v. 11, n. 3, p. 393, doi. 10.1007/s40119-022-00265-7
- By:
- Publication type:
- Article
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
- Published in:
- European Heart Journal, 2022, v. 43, n. 5, p. 391, doi. 10.1093/eurheartj/ehz173
- By:
- Publication type:
- Article
Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
- Published in:
- Vascular Health & Risk Management, 2021, v. 17, p. 661, doi. 10.2147/VHRM.S295376
- By:
- Publication type:
- Article
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Heart Journal, 2021, v. 42, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab072
- By:
- Publication type:
- Article
Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.
- Published in:
- Clinical Research in Cardiology, 2021, v. 110, n. 4, p. 579, doi. 10.1007/s00392-020-01801-y
- By:
- Publication type:
- Article
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 512, doi. 10.1002/ejhf.2140
- By:
- Publication type:
- Article
Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
- Published in:
- BMC Family Practice, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s12875-020-01252-4
- By:
- Publication type:
- Article
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
- Published in:
- Cardiovascular Drugs & Therapy, 2020, v. 34, n. 3, p. 357, doi. 10.1007/s10557-019-06919-4
- By:
- Publication type:
- Article
Amyloid cardiomyopathy.
- Published in:
- Herz, 2020, v. 45, n. 3, p. 267, doi. 10.1007/s00059-020-04904-4
- By:
- Publication type:
- Article
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 3, p. 703, doi. 10.1007/s00415-019-09602-8
- By:
- Publication type:
- Article
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
- Published in:
- Clinical Research in Cardiology, 2019, v. 108, n. 12, p. 1324, doi. 10.1007/s00392-019-01467-1
- By:
- Publication type:
- Article
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s12968-019-0564-1
- By:
- Publication type:
- Article
Was am Herzen nagt und auf die Nerven geht.
- Published in:
- Der Internist, 2018, v. 59, n. 11, p. 1208, doi. 10.1007/s00108-018-0470-x
- By:
- Publication type:
- Article
Predictors of survival stratification in patients with wild-type cardiac amyloidosis.
- Published in:
- Clinical Research in Cardiology, 2018, v. 107, n. 2, p. 158, doi. 10.1007/s00392-017-1167-1
- By:
- Publication type:
- Article
Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images--reference values and performance in patients with heart failure and left ventricular hypertrophy.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2017, v. 18, n. 12, p. 1414, doi. 10.1093/ehjci/jew324
- By:
- Publication type:
- Article
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0173086
- By:
- Publication type:
- Article
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 6319, doi. 10.2147/DDDT.S96893
- By:
- Publication type:
- Article
Fast assessment of long axis strain with standard cardiovascular magnetic resonance: a validation study of a novel parameter with reference values.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2015, v. 17, n. 1, p. 1, doi. 10.1186/s12968-015-0171-8
- By:
- Publication type:
- Article
Fast assessment of long axis strain with standard cardiovascular magnetic resonance: a validation study of a novel parameter with reference values.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2015, v. 17, n. 1, p. 69, doi. 10.1186/s12968-015-0171-8
- By:
- Publication type:
- Article
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Thickness of the midventricular left ventricular wall is predictive of survival in different forms of cardiac amyloidosis.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Non-invasive risk stratification of patients with TTR amyloidosis.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Amyloid in endomyocardial biopsies.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis.
- Published in:
- European Journal of Heart Failure, 2009, v. 11, n. 10, p. 1014, doi. 10.1093/eurjhf/hfp121
- By:
- Publication type:
- Article
Genetic microheterogeneity of human transthyretin detected by IEF.
- Published in:
- Electrophoresis, 2007, v. 28, n. 12, p. 2053, doi. 10.1002/elps.200600840
- By:
- Publication type:
- Article
Non-invasive predictors of survival in cardiac amyloidosis
- Published in:
- European Journal of Heart Failure, 2007, v. 9, n. 6/7, p. 617, doi. 10.1016/j.ejheart.2007.01.012
- By:
- Publication type:
- Article
Suspected cardiac amyloidosis: Endomyocardial biopsy remains the diagnostic gold-standard.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 4, p. 328, doi. 10.1002/ajh.20745
- By:
- Publication type:
- Article
Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats
- Published in:
- Cardiovascular Research, 2005, v. 67, n. 2, p. 283, doi. 10.1016/j.cardiores.2005.03.018
- By:
- Publication type:
- Article
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 5, p. 543, doi. 10.1111/j.1365-2141.2004.05232.x
- By:
- Publication type:
- Article